Literature DB >> 15494080

SOCS proteins in T helper cell differentiation: implications for allergic disorders?

Hiromasa Inoue1, Masato Kubo.   

Abstract

Asthma, allergic rhinitis and atopic dermatitis are allergic immune disorders characterised by a predominance of T helper 2 (Th2) cells, the resulting elevation of allergen-specific IgE, and mast-cell- and basophil-associated inflammation. The cytokine environment at the site of the initial antigen stimulation determines the direction of Th-cell differentiation into Th1 or Th2 cells. The SOCS (suppressor of cytokine signalling) proteins are implicated in the control of the balance between Th1 and Th2 cells in this process. SOCS3 is predominantly expressed in Th2 cells and inhibits Th1 differentiation; conversely, SOCS5 is expressed predominantly in Th1 cells and inhibits Th2 differentiation. Here, we discuss the role of SOCS proteins in Th-cell differentiation and explore the potential of SOCS proteins as targets for therapeutic strategies in allergic disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494080     DOI: 10.1017/S1462399404008348

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  6 in total

1.  Astragalin Attenuates Allergic Inflammation in a Murine Asthma Model.

Authors:  Jiping Liu; Yue Cheng; Xiaoshuang Zhang; Xue Zhang; Shuxian Chen; Zongmiao Hu; Chunmei Zhou; Enhu Zhang; Shiping Ma
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

2.  Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences.

Authors:  Arun Sankaradoss; Suraj Jagtap; Junaid Nazir; Shefta E Moula; Ayan Modak; Joshuah Fialho; Meenakshi Iyer; Jayanthi S Shastri; Mary Dias; Ravisekhar Gadepalli; Alisha Aggarwal; Manoj Vedpathak; Sachee Agrawal; Awadhesh Pandit; Amul Nisheetha; Anuj Kumar; Mahasweta Bordoloi; Mohamed Shafi; Bhagyashree Shelar; Swathi S Balachandra; Tina Damodar; Moses Muia Masika; Patrick Mwaura; Omu Anzala; Kar Muthumani; Ramanathan Sowdhamini; Guruprasad R Medigeshi; Rahul Roy; Chitra Pattabiraman; Sudhir Krishna; Easwaran Sreekumar
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 12.910

Review 3.  Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis.

Authors:  Spandana Rajendra Kopalli; Venkata Prakash Annamneedi; Sushruta Koppula
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

Review 4.  Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia.

Authors:  Masato Kubo; Hiromasa Inoue
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.919

5.  New drugs targeting Th2 lymphocytes in asthma.

Authors:  Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

6.  SOCS-3 inhibits E2F/DP-1 transcriptional activity and cell cycle progression via interaction with DP-1.

Authors:  Yoshikazu Masuhiro; Kenichi Kayama; Akie Fukushima; Koji Baba; Makio Soutsu; Yoshiaki Kamiya; Michio Gotoh; Noboru Yamaguchi; Shigemasa Hanazawa
Journal:  J Biol Chem       Date:  2008-08-07       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.